Literature DB >> 16502764

Placental transfer of antibiotics administered to the mother: a review.

G M Pacifici1.   

Abstract

BACKGROUND: The purpose of antibiotic treatment in pregnant women is to treat the mother and/or the fetus since it is known that antibiotics administered to the mother cross the placenta and reach the fetus. A comparison of the drug concentration in maternal and fetal plasma gives an indication of the exposure of the fetus to the maternally administered antibiotics. AIM: The aim of this study was to review the literature pertaining to the placental transfer of antibiotics in man and to classify the antibiotics according to the type of transfer involved. A table has been developed for use by physicians that lists the name of the antibiotic, the drug concentration in the cord and maternal plasma at delivery and the type of transfer involved.
METHODS: An initial medline search was performed with the key words "placental transfer of antibiotics" with the limit of "human". A second medline search was performed with the key words "placental transfer of..." followed by the class names of the antibiotic such as penicillins, cephalosporins, aminoglycosides, tetracyclines and macrolides. The bibliographic search on the placental transfer of antibiotics covered the period up to July 2005.
RESULTS: 3 types of placental transfers were identified. A few antibiotics cross the placenta rapidly and equilibrate in the maternal and cord plasma; this type of transfer is termed "complete" and include the antibiotics ampicillin, methicillin, cefmenoxime and cefotiam. Antibiotics which show incomplete transfer to the placenta where concentrations are lower in the cord than maternal plasma are said to have "incomplete" transfer and these include azlocillin, dicloxacillin, piperacillin, sulbenicillin, cefoxitin, amikacin, gentamicin, kanamycin, streptomycin, fosfomycin, thiamphenicol, griseofulvin, vancomycin and colistimethate. Ceftizoxime is the only antibiotic so far known whose concentrations are higher in the cord than maternal plasma. This type of transfer is called "exceeding" transfer.
CONCLUSION: All examined antibiotics cross the human placenta including those with a molecular weight greater than 1000 kDa such as vancomycin and colistimethate but there are 3 distinct types of placental transfer: complete, incomplete and exceeding and most antibiotics exhibit incomplete transfer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502764     DOI: 10.5414/cpp44057

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  12 in total

1.  Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity.

Authors:  N T Mueller; R Whyatt; L Hoepner; S Oberfield; M G Dominguez-Bello; E M Widen; A Hassoun; F Perera; A Rundle
Journal:  Int J Obes (Lond)       Date:  2014-10-09       Impact factor: 5.095

2.  Blood-Placental Barrier Transfers and Pharmacokinetics of Unbound Morphine in Pregnant Rats with Multiple Microdialysis Systems.

Authors:  I-Hsin Lin; Ling Yang; Thomas Y Hsueh; Tung-Hu Tsai
Journal:  ACS Pharmacol Transl Sci       Date:  2021-08-30

Review 3.  Excretion of biliary compounds during intrauterine life.

Authors:  Rocio I R Macias; Jose J G Marin; Maria A Serrano
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

4.  The Impact of Maternal Antibiotics on Neonatal Disease.

Authors:  Benjamin D Reed; Kurt R Schibler; Hitesh Deshmukh; Namasivayam Ambalavanan; Ardythe L Morrow
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

5.  Association of prenatal antibiotics with foetal size and cord blood leptin and adiponectin.

Authors:  N T Mueller; S L Rifas-Shiman; M J Blaser; M W Gillman; M-F Hivert
Journal:  Pediatr Obes       Date:  2016-03-07       Impact factor: 4.000

Review 6.  Early microbiota, antibiotics and health.

Authors:  Alicja M Nogacka; Nuria Salazar; Silvia Arboleya; Marta Suárez; Nuria Fernández; Gonzalo Solís; Clara G de Los Reyes-Gavilán; Miguel Gueimonde
Journal:  Cell Mol Life Sci       Date:  2017-10-07       Impact factor: 9.261

7.  In vitro resistance to macrolides and clindamycin by Group B Streptococcus isolated from pregnant and nonpregnant women.

Authors:  Antonietta Lambiase; Annalisa Agangi; Mariassunta Del Pezzo; Filomena Quaglia; Antonio Testa; Fabio Rossano; Pasquale Martinelli; Maria Rosaria Catania
Journal:  Infect Dis Obstet Gynecol       Date:  2012-05-20

Review 8.  Challenges in reducing group B Streptococcus disease in African settings.

Authors:  Yo Nishihara; Ziyaad Dangor; Neil French; Shabir Madhi; Robert Heyderman
Journal:  Arch Dis Child       Date:  2016-10-18       Impact factor: 3.791

Review 9.  Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Front Microbiol       Date:  2018-01-11       Impact factor: 5.640

10.  Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life.

Authors:  Linda Wampach; Anna Heintz-Buschart; Angela Hogan; Emilie E L Muller; Shaman Narayanasamy; Cedric C Laczny; Luisa W Hugerth; Lutz Bindl; Jean Bottu; Anders F Andersson; Carine de Beaufort; Paul Wilmes
Journal:  Front Microbiol       Date:  2017-05-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.